Publications by authors named "Jeff R Schein"

Claim this Profile
H
Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants.
Heather M Rozjabek, Craig I Coleman, Veronica Ashton, François Laliberté, Paul Oyefesobi, Jeff R Schein

J Med Econ· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
Manasi Datar, Concetta Crivera, Heather Rozjabek, Ibrahim M Abbass, Yihua Xu, Jeff R Schein

Am J Health Syst Pharm· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality.
Erin R Weeda, Christine G Kohn, W Frank Peacock, Gregory J Fermann, Concetta Crivera, Jeff R Schein

Clin Appl Thromb Hemost· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism?
Craig I Coleman, Gregory J Fermann, Erin R Weeda, Philip S Wells, Veronica Ashton, Jeff R Schein

Clin Appl Thromb Hemost· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies.
Christine G Kohn, Gregory J Fermann, W Frank Peacock, Phil S Wells, Christopher W Baugh, Jeff R Schein

Curr Med Res Opin· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans.
Christine G Kohn, Erin R Weeda, Neela Kumar, Philip S Wells, W Frank Peacock, Jeff R Schein

Intern Emerg Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin.
Erin R Weeda, Philip S Wells, W Frank Peacock, Gregory J Fermann, Christopher W Baugh, Jeff R Schein

Intern Emerg Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the multivariable 'In-hospital Mortality for PulmonAry embolism using Claims daTa' prediction rule in the Premier Hospital Database.
Elaine Nguyen, William Frank Peacock, Gregory J Fermann, Veronica Ashton, Concetta Crivera, Jeff R Schein

Eur Heart J Qual Care Clin Outcomes· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis.
Elaine Nguyen, Craig I Coleman, W Frank Peacock, Philip S Wells, Erin R Weeda, Jeff R Schein

BMC Pulm Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status.
Erin R Weeda, W Frank Peacock, Gregory J Fermann, Christopher W Baugh, Philip S Wells, Jeff R Schein

Int J Clin Pract· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism.
Erin R Weeda, W Frank Peacock, Gregory J Fermann, Philip S Wells, Veronica Ashton, Jeff R Schein

J Thromb Thrombolysis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban.
Erin R Weeda, Philip S Wells, W Frank Peacock, Gregory J Fermann, Christopher W Baugh, Jeff R Schein

Int J Cardiol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
Erin R Weeda, Christine G Kohn, W Frank Peacock, Gregory J Fermann, Concetta Crivera, Jeff R Schein

Pharmacotherapy· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications.
Craig I Coleman, W Frank Peacock, Gregory J Fermann, Concetta Crivera, Erin R Weeda, Jeff R Schein

BMC Health Serv Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis.
Erin R Weeda, Craig I Coleman, Colleen A McHorney, Concetta Crivera, Jeff R Schein

Int J Cardiol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribers' behavior following below- versus above-range international normalized ratio values in warfarin-treated deep vein thrombosis patients.
Monika K Raut, Winnie W Nelson, Sheng-Wei Wang, Craig I Coleman, Lang Lu, Jeff R Schein

Curr Med Res Opin· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
Mark J Alberts, W Frank Peacock, Larry E Fields, Thomas J Bunz, Elaine Nguyen, Jeff R Schein

Int J Cardiol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed.
Concetta Crivera, Winnie W Nelson, Jeff R Schein, Edward A Witt

Patient Prefer Adherence· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences.
Jeff R Schein, C Michael White, Winnie W Nelson, Jeffrey Kluger, Elizabeth S Mearns

Thromb J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches.
Erin R Weeda, Christine G Kohn, Gregory J Fermann, W Frank Peacock, Christopher Tanner, Jeff R Schein

Thromb J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis.
Kathleen Lang, Aarti A Patel, Michael Munsell, Brahim K Bookhart, Samir H Mody, Jeff R Schein

J Thromb Thrombolysis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
Beth L Nordstrom, Michael A Evans, Brian R Murphy, Edith A Nutescu, Jeff R Schein

Curr Med Res Opin· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.
Winnie W Nelson, Sunita Desai, C V Damaraju, Lang Lu, Larry E Fields, Jeff R Schein

Curr Med Res Opin· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal comorbidities associated with atrial fibrillation.
François Laliberté, Yuliya Moore, Katherine Dea, Joyce C LaMori, Samir H Mody, Jeff R Schein

Springerplus· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital length of stay of nonvalvular atrial fibrillation patients who were administered Rivaroxaban versus Warfarin with and without pretreatment parenteral anticoagulants therapies.
François Laliberté, Dominic Pilon, Monika K Raut, Winnie W Nelson, William H Olson, Jeff R Schein

Hosp Pract (1995)· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis